British pharma major AstraZeneca has established a new R&D center in Hong Kong, focused on research and development in areas including cell and gene therapies. 27 November 2023
Life science investor Syncona has announced that its newly-established portfolio company has entered into an agreement to buy the remaining stake in Freeline Th 22 November 2023
UK-based eXmoor pharma, a cell and gene therapy (CGT) manufacturing partner, has announced the hiring of Matthew Paterson as the company’s first chief commercia 15 November 2023
A Phase II failure for Californian cell therapy company Atara Biotherapeutics has prompted a share sell-off, with the company’s stock falling 80% in value on Th 10 November 2023
American biopharma company Vertex Pharmaceuticals has announced strong third quarter financial results and raised its guidance for product revenues in 2023. 7 November 2023
In line with a provisional report issued in September, the Boston, USA-based pricing watchdog the Institute for Clinical and Economic Review (ICER) has confirm 31 October 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.